Blog / Archives
Life Science Stocks Are Deal Driven: Alkermes (ALKS) and Elan(ELN) Merge Technologies
Good Technology Fit Helped By Cheap Money and Tax Benefits M&A has been one of the main drivers of the biotech market and today we have more recombinant action as Alkermes (ALKS) of Boston is...
Upbeat Jobs Report Boosts Market But Rally Fading, Biotechs Are Strong
Biotechs Rally Unphased by Macro Concerns The market loved the jobs report after the nasty commodity meltdown yesterday but other news intervened and buyers left for the weekend. The Dow was up as...
Reporting from the Milken Conference: The Promise of Medical Science
An excellent perspective on the Medical Sciences in a panel by leading scientists was presented Monday at the Milken Institute Global Conference, "Shaping the Future" at the Beverly Hilton in Los...
Profit Taking Hits Biotechnology Stocks
Biotechnology Sector Steps Back after Meteoric Rise Since Early March With many life science indices reaching new highs both YTD and in some cases over 10 years traders decided it was time to put...
Health and Biotechnology: A Top Performing Sector YTD Up 13.2%
According to data compiled by the Wall Street Journal on Monday May 2 page R8, the Health and Biotechnology sectors led the market (excluding gold oriented funds) in 2011 up 13.2% YTD and 6.7% in...
Rayno Diagnostics and Tools Market Update: GenProbe (GPRO),Illumina (ILMN),Quidel (QDEL)
Earnings season has begun with good results. Keep in mind the following trends: technology convergence, molecular diagnostics and M&A. The backdrop for the tools market is proposed government...
Rayno Life Science Portfolio Dx and Tools: GenProbe (GPRO) Soars On “For Sale”
Earnings season for diagnostics and tools companies begins today with GenProbe (GPRO $79.39) after the market close. But the stock is up 13% today on a Bloomberg scoop that the Company has hired...
Biotech Rocks On: Rayno Life Science Portfolio Up 2.2 % Led By Regeneron (REGN)
The biotech bulls are in charge this week. The sellers must have been watching the Bernanke Press Conference today or maybe buying gold as biotech stocks had one of their best days of the year. The...
Biotech Sector Ignited By Biogen-Idec (BIIB) and Vertex (VRTX)
Vertex (VRTX $54.17) soared 12.75% today on expectations for FDA approval of it telaprevir HCV drug Thursday April 28. Today FDA staff in a preliminary review commented that the Vertex drug when...
Rayno Life Science Market ReCap-Quiet Day but More Red than Green
Caution is still on as we have had big moves YTD and speculative stocks are selling off. High flyers Amarin (AMRN $16.10) is down 4.85% on volume of 6.85M shares while Ariad (ARIA $8.14) was down...